These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2838004

  • 21. Intestinal permeability in patients with yersinia triggered reactive arthritis.
    Lahesmaa-Rantala R, Magnusson KE, Granfors K, Leino R, Sundqvist T, Toivanen A.
    Ann Rheum Dis; 1991 Feb; 50(2):91-4. PubMed ID: 1998397
    [Abstract] [Full Text] [Related]

  • 22. Immune responses in yersinia-associated reactive arthritis.
    Aho K, Ahvonen P, Juvakoski T, Kousa M, Leirisalo M, Laitinen O.
    Ann Rheum Dis; 1979 Feb; 38 Suppl 1(Suppl 1):suppl 123-6. PubMed ID: 318096
    [No Abstract] [Full Text] [Related]

  • 23. Signalling profiles of circulating leucocytes in patients recovered from reactive arthritis.
    Alanärä T, Aittomäki S, Kuuliala K, Kuuliala A, Siitonen S, Leirisalo-Repo M, Repo H.
    Scand J Rheumatol; 2012 Aug; 41(4):267-74. PubMed ID: 22651550
    [Abstract] [Full Text] [Related]

  • 24. Yersinia arthritis: a clinical, immunological, and family study of 2 cases.
    Sheldon PJ, Mair NS, Fox E.
    Ann Rheum Dis; 1982 Apr; 41(2):153-8. PubMed ID: 6978685
    [Abstract] [Full Text] [Related]

  • 25. Yersinia reactive arthritis.
    Aho K.
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):41-5. PubMed ID: 6360291
    [Abstract] [Full Text] [Related]

  • 26. Yersinia antibodies in inflammatory joint diseases.
    Granfors K, Isomäki H, von Essen R, Maatela J, Kalliomäki JL, Toivanen A.
    Clin Exp Rheumatol; 1983 Nov; 1(3):215-8. PubMed ID: 6335856
    [Abstract] [Full Text] [Related]

  • 27. Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27.
    Leirisalo M, Skylv G, Kousa M, Voipio-Pulkki LM, Suoranta H, Nissilä M, Hvidman L, Nielsen ED, Svejgaard A, Tilikainen A, Laitinen O.
    Arthritis Rheum; 1982 Mar; 25(3):249-59. PubMed ID: 6978139
    [Abstract] [Full Text] [Related]

  • 28. [Articular manifestations of Yersinia infections. Apropos of 4 personal cases. Review of the literature].
    Magub M, Sany J, Le Peu G, Bertrand A, Blanc F, Bertrand L.
    Rev Rhum Mal Osteoartic; 1983 Feb; 50(2):115-24. PubMed ID: 6344185
    [Abstract] [Full Text] [Related]

  • 29. [Pathogenesis of infectious arthritis].
    Piaĭ LT.
    Revmatologiia (Mosk); 1983 Feb; (4):3-5. PubMed ID: 6199826
    [No Abstract] [Full Text] [Related]

  • 30. Depressed lymphocyte transformation by yersinia and Escherichia coli in yersinia arthritis.
    Leino R, Vuento R, Koskimies S, Viander M, Toivanen A.
    Ann Rheum Dis; 1983 Apr; 42(2):176-81. PubMed ID: 6342552
    [Abstract] [Full Text] [Related]

  • 31. Ten-year follow-up study of patients with Yersinia arthritis.
    Leirisalo-Repo M, Suoranta H.
    Arthritis Rheum; 1988 Apr; 31(4):533-7. PubMed ID: 2965876
    [Abstract] [Full Text] [Related]

  • 32. Yersinia arthritis in the Midlands: clinical and immunological features in ten cases during 1980-1983.
    Sheldon PJ, Pell P.
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):46-9. PubMed ID: 6606474
    [Abstract] [Full Text] [Related]

  • 33. Determination of oxygen radical production in spondyloarthropathies by whole blood chemiluminescence.
    Ristola M, Leirisalo-Repo M, Repo H.
    Ann Rheum Dis; 1991 Nov; 50(11):782-6. PubMed ID: 1772293
    [Abstract] [Full Text] [Related]

  • 34. Bacterial antigens in synovial biopsy specimens in yersinia triggered reactive arthritis.
    Merilahti-Palo R, Söderström KO, Lahesmaa-Rantala R, Granfors K, Toivanen A.
    Ann Rheum Dis; 1991 Feb; 50(2):87-90. PubMed ID: 1998396
    [Abstract] [Full Text] [Related]

  • 35. A tetrapeptide shared by Yersinia outer membrane protein Yop1 and HLA-B27. Antibody response in patients with Yersinia-triggered reactive arthritis.
    Lahesmaa R, Skurnik M, Granfors K, Möttönen T, Saario R, Toivanen A, Toivanen P.
    Scand J Rheumatol Suppl; 1990 Feb; 87():70-1. PubMed ID: 1701921
    [No Abstract] [Full Text] [Related]

  • 36. Does reduced erythrocyte C3b receptor (CR1) activity contribute to the pathogenesis of yersinia triggered reactive arthritis?
    Lahesmaa R, Eerola E, Toivanen A.
    Ann Rheum Dis; 1992 Jan; 51(1):97-100. PubMed ID: 1531747
    [Abstract] [Full Text] [Related]

  • 37. Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients.
    Biasi D, Carletto A, Caramaschi P, Bellavite P, Andrioli G, Caraffi M, Pacor ML, Bambara LM.
    Clin Exp Rheumatol; 1995 Jan; 13(5):623-7. PubMed ID: 8575141
    [Abstract] [Full Text] [Related]

  • 38. [Yersinia arthritis. Long-term follow up].
    Herrlinger JD, Asmussen JU.
    Z Rheumatol; 1993 Jan; 52(4):210-4. PubMed ID: 8212919
    [Abstract] [Full Text] [Related]

  • 39. Polymorphonuclear leucocyte motility in men with ankylosing spondylitis.
    Pease CT, Fennell M, Brewerton DA.
    Ann Rheum Dis; 1989 Jan; 48(1):35-41. PubMed ID: 2784306
    [Abstract] [Full Text] [Related]

  • 40. Effect of H-2 genes on expression of HLA-B27 and Yersinia-induced arthritis.
    Nickerson CL, Hogen KL, Luthra HS, David CS.
    Scand J Rheumatol Suppl; 1990 Jan; 87():85-90; discussion 90. PubMed ID: 2259892
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.